COMP <GO>
LQDA vs EWTX // ENTERPRISE SCALE & MARKET CAP
Liquidia Corporation (NASDAQ) VS. Edgewise Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: LQDA 6
— EWTX 5
▲ ENTERPRISE SCALE & MARKET CAP LEADER: EWTX
LAST: $41.85 (-7.12%) • MKT CAP: $4.03B
market-cap
$4.03B
LAST: $38.11 (-2.03%) • MKT CAP: $4.22B
market-cap
$4.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LQDA VS. EWTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LQDA | EWTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.60% | -31.90% | +19.30 | LQDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.99% | -3.41% | +2.42 | LQDA | /fcf-yield <GO> |
| Operating Margin | -32.50% | -16.20% | -16.30 | EWTX | /operating-margins <GO> |
| Net Profit Margin | -43.50% | 0.00% | -43.50 | EWTX | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | -1.10% | +181.10 | LQDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.33 | 26.00 | -19.67 | EWTX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 3/9 | +2.00 | LQDA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 45.7 | +6.80 | LQDA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 1.10 | -0.20 | EWTX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 25.0x | -4.00 | LQDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $4.03B | $4.22B | -$191.4M | EWTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LQDA REV | EWTX REV | LQDA GROSS % | EWTX GROSS % | LQDA FCF | EWTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $158.3M | $535.9M | — | — | -$40.0M | -$144.1M |
| FY 2024 | $14.0M | $444.7M | 58.0% | — | -$98.4M | -$110.3M |
| FY 2023 | $17.5M | $320.2M | — | — | -$42.4M | -$91.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LQDA // BETA 0.90
EWTX // BETA 1.10